Cargando…
A patient survey on the impact of alkaptonuria symptoms as perceived by the patients and their experiences of receiving diagnosis and care
BACKGROUND: Alkaptonuria (AKU) is an ultrarare and multifaceted disease characterized by the absence of functional homogentisate 1,2‐dioxygenase activity, the enzyme responsible for breakdown of homogentisic acid—a tyrosine‐degradation product. The presymptomatic phase of the disease makes diagnosis...
Autores principales: | Rudebeck, Mattias, Scott, Ciarán, Sireau, Nicolas, Ranganath, Lakshminarayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203644/ https://www.ncbi.nlm.nih.gov/pubmed/32395411 http://dx.doi.org/10.1002/jmd2.12101 |
Ejemplares similares
-
Effects of a protein‐restricted diet on body weight and serum tyrosine concentrations in patients with alkaptonuria
por: Olsson, Birgitta, et al.
Publicado: (2021) -
First decade anniversary of the United Kingdom National Alkaptonuria Centre
por: Khedr, Milad, et al.
Publicado: (2023) -
Nitisinone Treatment Affects Biomarkers of Bone and Cartilage Remodelling in Alkaptonuria Patients
por: Genovese, Federica, et al.
Publicado: (2023) -
Improving the clinical accuracy and flexibility of the Alkaptonuria severity score index
por: Cant, Harriet E. O., et al.
Publicado: (2022) -
Alkaptonuria: Current Perspectives
por: Zatkova, Andrea, et al.
Publicado: (2020)